TPX2基因沉默对膀胱癌耐药细胞株T24/DDP顺铂化疗敏感性的增强作用及其机制

张鹰,蒋先训,万朝辉

PDF(1569 KB)
PDF(1569 KB)
吉林大学学报(医学版) ›› 2024, Vol. 50 ›› Issue (2) : 346-354. DOI: 10.13481/j.1671-587X.20240207
基础研究

TPX2基因沉默对膀胱癌耐药细胞株T24/DDP顺铂化疗敏感性的增强作用及其机制

  • 张鹰1,蒋先训1(),万朝辉2
作者信息 +

Enhancement effect of TPX2 gene silencing on chemosensitivity of bladder cancer cell line T24/DDP to cisplatin and its mechanism

  • Ying ZHANG1,Xianxun JIANG1(),Zhaohui WAN2
Author information +
History +

摘要

目的 探讨爪蟾驱动蛋白样蛋白2靶蛋白(TPX2)基因沉默对膀胱癌耐药细胞株T24/顺铂(DDP)的化疗敏感性的影响,并阐明其作用机制。 方法 采用DDP浓度梯度刺激法建立DDP耐药细胞株T24/DDP,将细胞分为T24细胞组和T24/DDP细胞组。MTT法检测各组细胞增殖活性,并根据半数抑制浓度(IC50)值计算耐药指数(RI);实时荧光定量聚合酶链式反应(RT-qPCR)法和Western blotting法检测细胞中TPX2 mRNA及蛋白表达水平。通过小干扰RNA(siRNA)沉默T24/DDP细胞中TPX2基因表达,再将细胞分为空白对照组、阴性对照干扰(si-NC)组、TPX2沉默(si-TPX2)组、si-NC+DDP(2 mg·L-1 DDP)组和si-TPX2+DDP(2 mg·L-1 DDP)组。RT-qPCR法和Western blotting法检测转染后细胞中TPX2 mRNA及蛋白表达水平,MTT法检测各组细胞增殖活性,流式细胞术检测各组凋亡细胞率和细胞周期G2/M期百分率,Transwell小室实验检测各组迁移细胞数和侵袭细胞数,Western blotting法检测各组细胞中Wnt/β-连环蛋白(β-catenin)信号通路相关蛋白β-catenin、P-糖蛋白(P-gp)、锌指蛋白转录因子1(Snail1)和Survivin蛋白表达水平。 结果 成功建立膀胱癌DDP耐药细胞株T24/DDP,RI值为8.76。与T24细胞组比较,T24/DDP细胞组中TPX2 mRNA和蛋白表达水平明显升高(P<0.01)。与空白对照组和si-NC组比较,si-TPX2组T24/DDP细胞中TPX2 mRNA和蛋白表达水平明显降低(P<0.01),且DDP的IC50值明显降低(P<0.01)。与si-NC组比较,si-TPX2组T24/DDP细胞凋亡率和细胞周期G2/M期百分率明显升高(P<0.01),迁移细胞数和侵袭细胞数明显降低(P<0.01),T24/DDP细胞中β-catenin、P-gp、Snail1和Survivin蛋白表达水平明显降低(P<0.01);与si-NC+DDP组比较,si-TPX2+DDP组T24/DDP细胞凋亡率和细胞周期G2/M期百分率明显升高(P<0.01),迁移细胞数和侵袭细胞数明显降低(P<0.01),T24/DDP细胞中β-catenin、P-gp、Snail1和Survivin蛋白表达水平明显降低(P<0.01)。 结论 TPX2基因沉默通过抑制Wnt/β-catenin信号通路增强膀胱癌耐药细胞株T24/DDP对DDP的化疗敏感性。

Abstract

Objective To discuss the effect of gene silencing of targeting protein for Xenopus kinesin like protein 2 (TPX2) on the chemosensitivity of the resistant bladder cancer cell line T24/cisplatin(DDP), and to clarify the mechanism. Methods The DDP-resistant cell line T24/DDP was established by DDP concentration gradient induction method, and the cells were divided into T24 cell group and T24/DDP cell group. MTT method was used to detect the proliferation activities of the cells in various groups; the resistance index (RI) was calculated based on the half maximal inhibitory concentration (IC50) value;real-time fluorescence quantitative PCR (RT-qPCR) and Western blotting methods were used to detect the expression levels of TPX2 mRNA and protein in the cells in various groups; small interfering RNA (siRNA) was used to silence the TPX2 gene expression in the T24/DDP cells.The cells were divided into blank control group, negative control siRNA (si-NC) group, TPX2 silenced (si-TPX2) group, si-NC+DDP (2 mg·L-1 DDP) group,and si-TPX2+DDP (2 mg·L-1 DDP) group. RT-qPCR and Western blotting methods were used to detect the expression levels of TPX2 mRNA and protein in the cells in various groups; MTT method was used to detect the proliferation activity of the cells in various groups; flow cytometry was used to detect the apoptotic rates of the cells and percentages of the cells at G2/M phase in various groups; Transwell chamber assay was used to detect the numbers of migration and invasion cells; Western blotting method was used to detect the expression levels of Wnt/β-catenin signaling pathway-related proteins such as β-catenin, P-glycoprotein (P-gp), zinc finger protein transcription factor 1 (Snail1), and Survivin proteins in the cells in various groups. Results The resistant bladder cancer cell line T24/DDP was successfully established with the RI value of 8.76. Compared with T24 cell group, the expression levels of TPX2 mRNA and protein in the T24/DDP cells were significantly increased (P<0.01). Compared with blank control group and si-NC group, the expression levels of TPX2 mRNA and protein in the T24/DDP cells in si-TPX2 group were significantly decreased (P<0.01), and the IC50 value of DDP was significantly decreased (P<0.01). Compared with si-NC group, the apoptotic rate of the cells and the percentage of the cells at G2/M phase in si-TPX2 group was significantly increased (P<0.01), and the numbers of migration and invasion cells were significantly decreased (P<0.01), and the expression levels of β-catenin, P-gp, Snail1, and Survivin proteins in the T254/DDP cells were also significantly decreased (P<0.01). Compared with si-NC+DDP group, the apoptotic rate of the cells and percentage of the cells at G2/M phase in si-TPX2+DDP group were significantly increased (P<0.01), and the numbers of migration and invasion cells were significantly decreased (P<0.01), and the expression levels of β-catenin, P-gp, Snail1, and Survivin proteins in the T24/DDP cells were significantly decreased (P<0.01). Conclusion Gene silencing of TPX2 enhances the chemosensitivity of the resistant bladder cancer cell line T24/DDP to DDP by inhibiting the Wnt/β-catenin signaling pathway.

关键词

爪蟾驱动蛋白样蛋白2靶蛋白 / 膀胱肿瘤 / 顺铂 / 化疗敏感性 / Wnt/β-catenin信号通路

Key words

Targeting protein for Xenopus kinesinlike protein 2 / Bladder neoplasm / Cisplatin / Chemotherapy sensitivity / Wnt/β-catenin signaling pathway

中图分类号

R737.14

引用本文

导出引用
张鹰,蒋先训,万朝辉. TPX2基因沉默对膀胱癌耐药细胞株T24/DDP顺铂化疗敏感性的增强作用及其机制. 吉林大学学报(医学版). 2024, 50(2): 346-354 https://doi.org/10.13481/j.1671-587X.20240207
Ying ZHANG,Xianxun JIANG,Zhaohui WAN. Enhancement effect of TPX2 gene silencing on chemosensitivity of bladder cancer cell line T24/DDP to cisplatin and its mechanism[J]. Journal of Jilin University(Medicine Edition). 2024, 50(2): 346-354 https://doi.org/10.13481/j.1671-587X.20240207

参考文献

1 ZHENG W, ZHAO Y, WANG T, et al. Identification of hub genes associated with bladder cancer using bioinformatic analyses[J].Transl Cancer Res,2022,11(5):1330-1343.
2 SHEN P, HE X, LAN L, et al. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis[J]. Biosci Rep, 2020, 40(7):BSR20194429.
3 DOBRUCH J, OSZCZUDLOWSKI M. Bladder cancer: current challenges and future directions[J]. Medicina (Kaunas), 2021, 57(8):749.
4 REN D, LI L, WANG S, et al. The c-MYC transcription factor conduces to resistance to cisplatin by regulating MMS19 in bladder cancer cells[J]. Tissue Cell,2023, 82:102096.
5 CHEN J, LI Y, LI Z, et al. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling[J]. J Biochem Mol Toxicol, 2020, 34(4):e22452.
6 CHEN MK, ZHOU JH, WANG P, et al. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell[J]. Aging (Albany NY), 2021, 13(14):18310-18330.
7 LIU T, ZHANG Z, WANG C, et al. BRD4 promotes the migration and invasion of bladder cancer cells through the Sonic hedgehog signaling pathway and enhances cisplatin resistance[J]. Biochem Cell Biol,2022,100(2):179-187.
8 SHAO T, JIANG X, BAO G, et al. Comprehensive analysis of the oncogenic role of targeting protein for Xklp2 (TPX2) in human malignancies[J]. Dis Markers,2022, 2022:7571066.
9 YAN X, GUO Z X, LIU X P, et al. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis[J]. J Cell Physiol, 2019, 234(10):19073-19087.
10 YAN L, LI Q, YANG J, et al. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer[J]. J Cell Biochem,2018, 119(2):1791-1803.
11 YANG C, SHEN S, ZHENG X, et al. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4[J]. FASEB J, 2020, 34(5):6055-6069.
12 王鹏, 陈明坤, 陈子坚, 等. 膀胱癌T24细胞顺铂与吉西他滨多药耐药细胞株的建立及其生物学特征[J]. 中华实验外科杂志, 2018, 35(4):716-718.
13 ALI R, AOUIDA M, ALHAJl S A, et al. Can cisplatin therapy be improved? Pathways that can be targeted[J]. Int J Mol Sci, 2022, 23(13):7241.
14 MENG X, CAO J, ZHENG H, et al. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability[J]. Cancer Med,2023, 12(8):9738-9748.
15 WANG Q, GENG F, ZHOU H, et al. MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway[J]. Oncol Lett, 2019, 18(4):4294-4307.
16 田宇佳, 魏 铭, 赵 辉. Wnt/β-catenin信号通路在肿瘤干细胞中的作用研究进展[J]. 解放军医学杂志, 2022, 47(8): 831-837.
17 MENG Z Q, ZHANG R, WU X W, et al. Ginsenoside Rg3 regulates cisplatin resistance in gastric cancer by Wnt/β-catenin signaling pathway[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2022, 44(3):366-376.
18 ZHANG J, XIE T, ZHONG X, et al. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway[J].Aging (Albany NY),2020,12(6):5423-5438.
19 ZHENG J, LI X, CAI C, et al. MicroRNA-32 and MicroRNA-548a promote the drug sensitivity of non-small cell lung cancer cells to cisplatin by targeting ROBO1 and inhibiting the activation of Wnt/β-catenin axis[J]. Cancer Manag Res, 2021, 13:3005-3016.
20 DING L, ZHANG S, CHEN S, et al. Effect and mechanism of lentivirus- mediated silencing of TPX2 gene on proliferation and apoptosis of human hepatoma cells[J]. J Cell Biochem, 2019, 120(5):8352-8358.

基金

湖南省卫健委一般指导科研项目(D202304058812)

评论

PDF(1569 KB)

Accesses

Citation

Detail

段落导航
相关文章

/